CalciMedica, Inc.
Datakwaliteit: 83%
CALC
Nasdaq
Manufacturing
Chemicals
€ 0,66
▲
€ 0,04
(6,42%)
Marktkapitalisatie: 10,44 M
Prijs
€ 0,66
Marktkapitalisatie
10,44 M
Dagbereik
€ 0,61 — € 0,70
52-Weeksbereik
€ 0,46 — € 7,20
Volume
434.085
Openen € 0,62
50D / 200D Gem.
€ 0,94
29,20% below
50D / 200D Gem.
€ 2,86
76,81% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -21,21 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-1013,26%
Onder sectorgemiddelde (-53,41%)
ROIC-136,13%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio4,04
Interest Coverage-16,26
Waardering
PE (TTM)
-0,35
Boven sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,4 | -1,5 |
| P/B | — | 1,6 |
| ROE % | -1013,3 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -29,56 M |
| ROE | -1013,26% | ROA | -173,93% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -21,21 M |
| ROIC | -136,13% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4,04 |
| Interest Coverage | -16,26 | Asset Turnover | N/A |
| Working Capital | 11,17 M | Tangible Book Value | -268.000 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,35 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -203,22% | ||
| Market Cap | 10,44 M | Enterprise Value | 4,97 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,97 | Revenue / Share | N/A |
| FCF / Share | -1,35 | OCF / Share | -1,35 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 71,73% |
| SBC-Adj. FCF | -24,34 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -29,56 M | -13,70 M | -34,36 M | -35,61 M | -35,82 M |
| EPS (Diluted) | -1,97 | -1,22 | -7,66 | -1,66 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -23,12 M | -24,20 M | -38,08 M | -36,18 M | -35,95 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 15,23 M | 14,48 M | 15,86 M | 14,11 M | 18,90 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | 58.000,0 | — | — |
| Interest Expense | 1,42 M | — | — | — | — |
| Income Tax | 0,0 | 0,0 | 1.000,0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13,59 M | 19,79 M | 12,19 M | 39,67 M | 69,09 M |
| Total Liabilities | 20,23 M | 5,38 M | 4,03 M | 3,70 M | 4,07 M |
| Shareholders' Equity | -6,64 M | 14,41 M | 8,16 M | 35,97 M | 65,02 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 11,52 M | 7,94 M | 5,53 M | 17,30 M | 13,36 M |
| Current Assets | 13,53 M | 19,67 M | 11,61 M | 39,67 M | 67,08 M |
| Current Liabilities | 3,78 M | 3,68 M | 4,03 M | 3,70 M | 4,06 M |
{"event":"ticker_viewed","properties":{"ticker":"CALC","listing_kind":"stock","pathname":"/stocks/calc","exchange":"Nasdaq","country":"US"}}